A trio of Democratic senators want Novo Nordisk to explain why it discontinued one of its long-acting insulin products after it announced a steep price cut on the medication. Sens. Jeanne Shaheen ...

Novo Nordisk is discontinuing one ... Luckily, there are many alternative insulins, both rapid-acting and long-acting. Zilbermint highlights Lantus (insulin glargine) as a good option.

Novo Nordisk is also pairing the long-acting insulin with its once-weekly GLP-1 agonist semaglutide in the COMBINE trials programme, which is due to complete in 2024, is also working on a glucose ...

Novo Nordisk has said that the introduction ... That suggests its top-selling insulin products like rapid-acting NovoRapid (insulin aspart), premix NovoMix (insulin aspart/insulin aspart protamine ...

COPENHAGEN, Dec 5 (Reuters) - Danish drug maker Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% from January of ...

In 1985, Novo Nordisk pioneered production of recombinant human insulin in yeast. In 1999, we introduced rapid-acting and, in 2004, long-acting insulin analogues produced by genetic engineering ...

Sikkim Casino entry fee Fountain Medical Completes $62 Million Series D Financing Novo Nordisk's Fiasp (rapid-acting insulin aspart) has been ap ...